APREMILAST (OTEZLA) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

APREMILAST

What is the Trade Name for APREMILAST

OTEZLA

What is the Indication for APREMILAST

  • 1 INDICATIONS AND USAGE OTEZLA, an inhibitor of phosphodiesterase 4 (PDE4), is indicated for the treatment of: Adult patients with active psoriatic arthritis ( 1.1 ) Patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy ( 1.2 ) Adult patients with oral ulcers associated with Beh√ßet’s Disease ( 1.3 ) 1.1 Psoriatic Arthritis OTEZLA is indicated for the treatment of adult patients with active psoriatic arthritis. 1.2 Psoriasis OTEZLA is indicated for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. 1.3 Oral Ulcers Associated with Beh√ßet’s Disease OTEZLA is indicated for the treatment of adult patients with oral ulcers associated with Beh√ßet’s Disease.

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]